In the last trading session, 2.88 million shares of the Amneal Pharmaceuticals Inc (NASDAQ:AMRX) were traded, and its beta was 1.33. Most recently the company’s share price was $6.06, and it changed around -$0.06 or -0.98% from the last close, which brings the market valuation of the company to $1.87B. AMRX currently trades at a discount to its 52-week high of $6.46, offering almost -6.6% off that amount. The share price’s 52-week low was $1.24, which indicates that the current value has risen by an impressive 79.54% since then. We note from Amneal Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 1.97 million shares, with the 3-month average coming to 1.48 million.
Amneal Pharmaceuticals Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.00. If we narrow it down even further, the data shows that 1 out of 6 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended AMRX as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Amneal Pharmaceuticals Inc is expected to report earnings per share of $0.09 for the current quarter.
Amneal Pharmaceuticals Inc (NASDAQ:AMRX) trade information
Instantly AMRX has showed a red trend with a performance of -0.98% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently down -0.16% year-to-date, but still down -3.66% over the last five days. On the other hand, Amneal Pharmaceuticals Inc (NASDAQ:AMRX) is 9.78% up in the 30-day period. We can see from the shorts that 2.07 million shares have been sold at a short interest cover period of 1.32 day(s).
The consensus price target as assigned by Wall Street analysts is $6, which translates to bulls needing to decrease their stock price by -1.0% from its current value. Analyst projections state that AMRX is forecast to be at a low of $4 and a high of $8.
Amneal Pharmaceuticals Inc (AMRX) estimates and forecasts
Amneal Pharmaceuticals Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 45.32 percent over the past six months and at a -10.94% annual growth rate that is well below the industry average of 8.20%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will loss -25.00% in revenue this quarter, and will report a decrease of -26.30% in the next quarter. The year-over-year growth rate is expected to be 9.00%, up from the previous year.
Consensus estimates provided by 4 financial analysts predict the company will bring in an average of $618.12 million in revenue for the current quarter. 4 analysts expect Amneal Pharmaceuticals Inc to make $650.37 million in revenue for the quarter ending Jun 2024. The company’s sales for the same quarters a year ago were $557.54 million and $599.05 million respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 10.90%. Forecasts for the next quarter put sales growth at 8.60%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -23.74%. Amneal Pharmaceuticals Inc earnings are expected to increase by -8.93% in 2024, but the outlook is negative -1.50% per year for the next five years.
AMRX Dividends
Amneal Pharmaceuticals Inc’s next quarterly earnings report is expected to be released around February 29 and March 04.
Amneal Pharmaceuticals Inc (NASDAQ:AMRX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 52.91% of Amneal Pharmaceuticals Inc shares, and 35.94% of them are in the hands of institutional investors. The stock currently has a share float of 76.32%. Amneal Pharmaceuticals Inc stock is held by 203 institutions, with Fosun International Ltd being the largest institutional investor. By Jun 29, 2023, it held 13.96% of the shares, which is about 21.52 million shares worth $66.72 million.
Vanguard Group Inc, with 8.52% or 13.14 million shares worth $40.72 million as of Jun 29, 2023, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Small-Cap Index Fund were the top two Mutual Funds as of Jun 29, 2023. The former held 3.99 million shares worth $12.37 million, making up 2.59% of all outstanding shares. On the other hand, Vanguard Small-Cap Index Fund held roughly 3.56 million shares worth around $11.05 million, which represents about 2.31% of the total shares outstanding.
